✦ LIBER ✦

A phase II study of raltitrexed and gemcitabine in patients with advanced pancreatic carcinoma

✍ Scribed by Arends, J J; Sleeboom, H P; Leys, M B L; ten Bokkel Huinink, D; de Jong, R S; Smit, J M; Nortier, J W R; Tesselaar, M E T

Book ID: 109998392
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 85 KB
Volume: 92
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6602368

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of gemcitabine in patient

Phase II study of gemcitabine in patients with advanced hepatocellular carcinoma

✍ Tai-Shen Yang; Yung-Chang Lin; Jen-Shi Chen; Hung-Ming Wang; Chen-Hsu Wang 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 3 views

Phase II study of gemcitabine and cispla

Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma

✍ Philip A. Philip; Mark M. Zalupski; V. K. Vaitkevicius; Patricia Arlauskas; Ruth 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

A Phase II study of gemcitabine and doce

A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma

✍ David P. Ryan; Matthew H. Kulke; Charles S. Fuchs; Michael L. Grossbard; Steven 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

A phase I/II multicentric trial of gemci

A phase I/II multicentric trial of gemcitabine and epirubicin in patients with advanced pancreatic carcinoma

✍ Eickhoff, A; Martin, W; Hartmann, D; Eickhoff, J C; Möhler, M; Galle, P R; Riema 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 73 KB

A phase II study of gemcitabine and doce

A phase II study of gemcitabine and docetaxel therapy in patients with advanced urothelial carcinoma

✍ Barbara J. Gitlitz; Carole Baker; Yvonne Chapman; Heather J. Allen; Linda D. Bos 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

## Abstract ## BACKGROUND The objectives of the current study were to evaluate the safety and efficacy of gemcitabine plus docetaxel in patients with unresectable (Stage T4 or ≥ N1) metastatic or locally advanced transitional cell carcinoma (TCC) of the urothelial tract. ## METHODS A total of 27

Phase II study of S-1 in patients with g

Phase II study of S-1 in patients with gemcitabine-resistant advanced pancreatic cancer

✍ Kentaro Sudo; Taketo Yamaguchi; Kazuyoshi Nakamura; Tadamichi Denda; Taro Hara; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 182 KB